- H.C. Wainwright initiates coverage on Cidara Therapeutics (NASDAQ:CDTX) with a Buy rating and $25 (136% upside) price target.
- Janney Capital initiates coverage on Acorda Therapeutics (NASDAQ:ACOR) with a Neutral rating and $23 (23% upside) price target.
- Piper Jaffray initiates coverage on Recro Pharma (NASDAQ:REPH) with an Overweight rating and $12 (68% upside) price target.
- Oppenheimer upgrades DexCom (NASDAQ:DXCM) to Outperform from Perform.
- Jefferies upgrades Bristol-Myers Squibb (NYSE:BMY) to Buy from Hold.
- Jefferies downgrades Merck (NYSE:MRK) to Underperform from Hold.
Today's healthcare analyst action
Recommended For You
More Trending News
About CDTX Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
CDTX | - | - |
Cidara Therapeutics, Inc. |